Bio-Rad Laboratories Debt to Equity Ratio 2010-2023 | BIO.B
Current and historical debt to equity ratio values for Bio-Rad Laboratories (BIO.B) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bio-Rad Laboratories debt/equity for the three months ending March 31, 2023 was 0.12.
| Bio-Rad Laboratories Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-03-31 |
$3.90B |
$9.76B |
0.40 |
| 2022-12-31 |
$3.89B |
$9.62B |
0.40 |
| 2022-09-30 |
$3.61B |
$8.45B |
0.43 |
| 2022-06-30 |
$3.76B |
$8.92B |
0.42 |
| 2022-03-31 |
$4.19B |
$10.18B |
0.41 |
| 2021-12-31 |
$4.11B |
$13.69B |
0.30 |
| 2021-09-30 |
$4.62B |
$15.33B |
0.30 |
| 2021-06-30 |
$3.52B |
$11.60B |
0.30 |
| 2021-03-31 |
$3.32B |
$10.61B |
0.31 |
| 2020-12-31 |
$3.09B |
$9.88B |
0.31 |
| 2020-09-30 |
$3.20B |
$8.83B |
0.36 |
| 2020-06-30 |
$2.74B |
$7.35B |
0.37 |
| 2020-03-31 |
$2.39B |
$6.29B |
0.38 |
| 2019-12-31 |
$2.25B |
$5.76B |
0.39 |
| 2019-09-30 |
$2.05B |
$5.13B |
0.40 |
| 2019-06-30 |
$2.16B |
$5.49B |
0.39 |
| 2019-03-31 |
$2.00B |
$4.86B |
0.41 |
| 2018-12-31 |
$1.59B |
$4.02B |
0.40 |
| 2018-09-30 |
$1.82B |
$4.90B |
0.37 |
| 2018-06-30 |
$1.75B |
$4.64B |
0.38 |
| 2018-03-31 |
$1.73B |
$4.49B |
0.39 |
| 2017-12-31 |
$1.34B |
$2.93B |
0.46 |
| 2017-09-30 |
$1.34B |
$2.85B |
0.47 |
| 2017-06-30 |
$1.33B |
$2.81B |
0.47 |
| 2017-03-31 |
$1.25B |
$2.71B |
0.46 |
| 2016-12-31 |
$1.27B |
$2.58B |
0.49 |
| 2016-09-30 |
$1.32B |
$2.70B |
0.49 |
| 2016-06-30 |
$1.26B |
$2.62B |
0.48 |
| 2016-03-31 |
$1.21B |
$2.54B |
0.48 |
| 2015-12-31 |
$1.22B |
$2.49B |
0.49 |
| 2015-09-30 |
$1.24B |
$2.43B |
0.51 |
| 2015-06-30 |
$1.17B |
$2.36B |
0.49 |
| 2015-03-31 |
$1.13B |
$2.20B |
0.51 |
| 2014-12-31 |
$1.16B |
$2.19B |
0.53 |
| 2014-09-30 |
$1.21B |
$2.18B |
0.56 |
| 2014-06-30 |
$1.22B |
$2.25B |
0.54 |
| 2014-03-31 |
$1.21B |
$2.23B |
0.54 |
| 2013-12-31 |
$1.20B |
$2.19B |
0.55 |
| 2013-09-30 |
$1.16B |
$2.12B |
0.54 |
| 2013-06-30 |
$1.41B |
$2.07B |
0.68 |
| 2013-03-31 |
$1.43B |
$2.03B |
0.70 |
| 2012-12-31 |
$1.43B |
$2.02B |
0.71 |
| 2012-09-30 |
$1.37B |
$1.94B |
0.71 |
| 2012-06-30 |
$1.32B |
$1.85B |
0.71 |
| 2012-03-31 |
$1.35B |
$1.84B |
0.73 |
| 2011-12-31 |
$1.35B |
$1.74B |
0.78 |
| 2011-09-30 |
$1.28B |
$1.69B |
0.75 |
| 2011-06-30 |
$1.32B |
$1.73B |
0.76 |
| 2011-03-31 |
$1.30B |
$1.61B |
0.80 |
| 2010-12-31 |
$1.52B |
$1.54B |
0.99 |
| 2010-09-30 |
$1.25B |
$1.43B |
0.88 |
| 2010-06-30 |
$1.22B |
$1.30B |
0.94 |
| 2010-03-31 |
$1.25B |
$1.30B |
0.96 |
| 2009-12-31 |
$1.26B |
$1.28B |
0.98 |
| 2009-09-30 |
$1.25B |
$1.23B |
1.02 |
| 2009-06-30 |
$1.22B |
$1.13B |
1.08 |
| 2009-03-31 |
$0.90B |
$1.06B |
0.85 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.071B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
